Home  »  News   »  Analyzing the Impact of Earnings Reports on Caribo...

Analyzing the Impact of Earnings Reports on Caribou Biosciences Inc. Inc. (CRBU) Price Performance

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -16.32% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 5.95%. Over the past 30 days, the price of CRBU has leaped by -14.13%. And in the last five days, it has fallen by -17.76%.

The current stock price for Caribou Biosciences Inc. (CRBU) is $5.26. The stock experienced a significant increase during the last trading session, reaching $5.79 after opening at $5.79. It dipped to a low of $5.25 before ultimately closing at $5.86.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


In terms of market performance, Caribou Biosciences Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $12.40 on 09/20/22, while the lowest value was $3.96 on 06/27/23.

52-week price history of CRBU Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Caribou Biosciences Inc.’s current trading price is -57.62% away from its 52-week high, while its distance from the 52-week low is 32.70%. The stock’s price range for this period has been between $3.96 and $12.40. The Healthcare sector company’s shares saw a trading volume of about 2.06 million for the day, which was lower than the average daily volume of 3.59 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Caribou Biosciences Inc. (CRBU) has experienced a quarterly rise of 21.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 447.31M and boasts a workforce of 137 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.49, with a change in price of +0.95. Similarly, Caribou Biosciences Inc. recorded 2,507,192 in trading volume during the last 100 days, posting a change of +22.21%.

CRBU’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CRBU stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

CRBU Stock Stochastic Average

As of today, the raw stochastic average of Caribou Biosciences Inc. over the past 50 days is 0.15%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 0.40%. Additionally, the Stochastic %K and %D values for the company were 13.25% and 15.04%, respectively, over the past 20 days.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts